White matter disease as a biomarker for long-term cerebrovascular disease and dementia

Aurauma Chutinet1, Natalia S Rost

  • 1Division of Neurology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Thai Red Cross, 1873, Rama IV Road, Bangkok, 10330, Thailand, aurauma@yahoo.com.

Abstract

Insights

White matter hyperintensities (WMH) on brain MRI are markers of small vessel disease in aging individuals. Increased WMH indicate higher lifelong risks for stroke, cognitive decline, and disability.

Area of Science:

  • Neuroimaging
  • Cerebrovascular Disease
  • Aging Research

Background:

  • White matter disease is frequently observed in aging brains via MRI as white matter hyperintensities (WMH), also known as leukoaraiosis.
  • WMH are recognized as radiographic indicators of underlying small cerebral vessel disease.
  • Population-based studies highlight WMH as a significant biomarker for long-term cerebrovascular conditions and dementia risk.

Purpose of the Study:

  • To review the conceptual framework and methodologies linking WMH to cerebrovascular disease.
  • To connect current knowledge on WMH with future research directions.
  • To underscore the predictive value of WMH for stroke, cognitive impairment, and functional disability.

Main Methods:

  • Review of existing literature and population-based studies.
  • Analysis of conceptual frameworks for understanding WMH.
  • Synthesis of current knowledge on WMH as a biomarker.

Main Results:

  • WMH are established radiographic markers of small cerebral vessel disease.
  • The extent of WMH predicts long-term risk of stroke, cognitive impairment, and functional disability.
  • WMH serve as a significant biomarker in population studies for cerebrovascular disease and dementia.

Conclusions:

  • The presence and extent of WMH on brain MRI are crucial indicators of cerebrovascular health in aging.
  • Understanding WMH is vital for predicting lifelong risks associated with small vessel disease.
  • Further research is needed to fully elucidate the implications and management of WMH.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K